HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Urinary Bladder Diseases (Bladder Diseases)

Subscribe to New Research on Urinary Bladder Diseases

Pathological processes of the URINARY BLADDER.

Also Known As:

Bladder Diseases; Bladder Disease; Urinary Bladder Disease

Networked: 110 relevant articles (6 outcomes, 13 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1.	Infection
2.	Pain (Aches)
3.	Dysuria
4.	Nocturia
5.	Pseudomonas Infections

Experts

1.	Yoshimura, Naoki: 4 articles (01/2014 - 05/2004)
2.	Tyagi, Pradeep: 3 articles (01/2014 - 05/2004)
3.	Chancellor, Michael B: 3 articles (08/2009 - 12/2006)
4.	Chancellor, Michael: 2 articles (01/2014 - 05/2004)
5.	Porena, Massimo: 2 articles (07/2013 - 12/2006)
6.	Costantini, Elisabetta: 2 articles (07/2013 - 12/2006)
7.	Woolf, Adrian S: 2 articles (11/2011 - 07/2006)
8.	Wilcox, Duncan T: 2 articles (11/2011 - 07/2006)
9.	Oottamasathien, Siam: 2 articles (10/2011 - 10/2008)
10.	Philips, Brian J: 2 articles (08/2009 - 02/2009)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Urinary Bladder Diseases:

1.	Cimetidine (Biomet)FDA LinkGeneric 09/01/2001 - "Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial." 02/01/2001 - "Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial." 02/01/2001 - "To evaluate the efficacy of oral cimetidine as a treatment for painful bladder disease (PBD, variously described as a 'symptom complex' of suprapubic pain, frequency, dysuria and nocturia in the absence of overt urine infection) by assessing symptom relief and histological changes in the bladder wall tissue components, compared with placebo. "
2.	Norfloxacin FDA Link 02/21/1986 - "Patients with neurological bladder disease were cured in a relatively high percentage of their Pseudomonas infection after three months treatment with norfloxacin. "
3.	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/01/1992 - "In this case, only cyclophosphamide markedly improved the protein-losing enteropathy but did not influence the bladder disease."
4.	Acrolein (Aqualin)IBA 10/01/2014 - "Empty LPs alone provide a therapeutic efficacy against acrolein-induced changes in urothelial cell viability and may be a promising local therapy for bladder diseases. "
5.	GlycosaminoglycansIBA 07/01/2013 - "Furthermore, we will underline the role of glycosaminoglycans, focusing both on their pathophysiological role in the principal bladder diseases and on the therapeutic aspects from the clinical point of view. " 02/01/1994 - "Polysaccharide therapy for bladder disease is a novel therapy based on the model of bladder mucus activity and the belief that mucus and exogenous glycosaminoglycans (GAG) have protective properties. " 02/01/1997 - "The long-term objective of this study is to elucidate the role of bladder mucosal glycosaminoglycans and mucin glycoproteins in the development of interstitial cystitis and other bladder diseases. "
6.	CreatinineIBA 01/01/1996 - "None of the 52 patients with benign conditions, nine of the 27 with Ta-T1, and nine of the 25 with T2-T4 bladder disease had urinary total beta-hCG levels > 3.74 IU/mmol/L creatinine. " 01/01/1993 - "In a cross-section study the levels of urine laminin P1 expressed as a laminin P1:creatinine ratio were determined in 25 patients with superficial (noninvasive) transitional cell carcinoma (TCC) of the bladder, 12 patients with invasive TCC, 15 patients with inflammatory bladder diseases and 50 healthy controls. "
7.	AntibodiesIBA 09/01/2015 - "BK virus (BKV) is associated with kidney and bladder disease after hematopoietic cell transplantation (HCT) but less is known about the seroprevalence of pre-transplant antibodies to BKV in children. " 07/01/1996 - "In an initial study of anti-nuclear antibodies in the chronic inflammatory bladder disease interstitial cystitis, we reported that 7% of interstitial cystitis patients studied had autoantibodies to the nucleolus. "
8.	MicroRNAs (MicroRNA)IBA 10/01/2012 - "Findings of this study indicated results of miRNA expression assays can be used to distinguish between samples of grossly normal bladders and bladders of dogs with inflammatory bladder disease or TCC. " 10/01/2012 - "To determine expression of microRNA (miRNA) in urinary bladder samples obtained from dogs with grossly normal urinary bladders, inflammatory bladder disease, or transitional cell carcinoma (TCC) and in cells of established canine TCC cell lines. " 10/01/2012 - "Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma."
9.	Protein Isoforms (Isoforms)IBA 08/01/2001 - "To study the expression of the endothelial and inducible isoforms of nitric oxide synthase (eNOS and iNOS, respectively) in human bladder carcinoma and schistosomal bladder disease, and to compare it with normal adult and fetal urothelium. "
10.	Nitric Oxide Synthase (NO Synthase)IBA 08/01/2001 - "To study the expression of the endothelial and inducible isoforms of nitric oxide synthase (eNOS and iNOS, respectively) in human bladder carcinoma and schistosomal bladder disease, and to compare it with normal adult and fetal urothelium. "

Therapies and Procedures

1.	Endoscopes 01/01/1989 - "[The efficacy of rigid and flexible endoscopes in the diagnosis of bladder diseases]." 11/01/2003 - "[Experience in the clinical application of semirigid mini-urethral endoscopes in the diagnosis and treatment of urinary bladder diseases]." 01/01/1989 - "A comparative assessment of the efficiency of rigid and flexible endoscopes used for the diagnosis of bladder diseases (cystitis, papilloma, carcinoma in a total of 250 patients) is reported. "
2.	Drug Therapy (Chemotherapy) 01/01/2014 - "Adoption of forward-thinking approaches can achieve advancements in drug delivery systems targeted to future improvement in pharmacotherapy of bladder diseases. " 05/01/1998 - "For prostatic disease only primary surgical therapy was associated with prolonged survival, while for bladder disease cisplatin chemotherapy was associated with a favorable prognosis. "
3.	Radiotherapy 04/01/2009 - "Historic comparisons with other studies indicate no evidence of an increase in severe or worse adverse events and good permanent control of bladder disease after ARCON radiotherapy." 01/01/1985 - "A double-blind study with Serocytol "Muqueuse urinaire" (immune serum against mucosa of the urinary tract) and Serocytol "S.R.E." (immune serum against reticulo-endothelial system) and placebo was designed for treatment of different bladder diseases (interstitial cystitis sui generis, after radiotherapy and in connection with multiple transurethral resections of bladder tumour, cystitis granularis). "
4.	Intravesical Administration 11/01/2011 - "Because of its high affinity for the bladder, both systemically as reported in previous studies and after intravesical instillation as reported in the present study, R11 should be further tested in animal models as a delivery vector for agents used in treating bladder diseases." 09/01/2007 - "Eosinophilic cystitis is a rare and uncommon inflammatory bladder disease, in which the pathophysiology is unclear; only a few cases of such disease induced by intravesical instillations have been described. "
5.	Heterologous Transplantation (Xenotransplantation) 02/01/2011 - "On the other hand, the pig shows similarity in size, shape and physiology to human and has been used as a major mammalian model for many studies concerning xenotransplantation, cardiovascular diseases, blood dynamics, nutrition, general metabolic functions, digestive-related disorders, respiratory diseases, diabetes, kidney and bladder diseases, organ-specific toxicity, dermatology and neurological sequelae. "